Glyphosate-based herbicides: Evidence of immune-endocrine alteration.


Journal

Toxicology
ISSN: 1879-3185
Titre abrégé: Toxicology
Pays: Ireland
ID NLM: 0361055

Informations de publication

Date de publication:
07 2021
Historique:
received: 09 03 2021
revised: 10 06 2021
accepted: 06 07 2021
pubmed: 12 7 2021
medline: 13 8 2021
entrez: 11 7 2021
Statut: ppublish

Résumé

Glyphosate (G) is the active ingredient of the most widely used herbicide products. It targets the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which lacks in humans, suggesting to confer a low mammalian toxicity to G-based herbicides (GBHs). Despite this, the use of G is currently under intense debate. Many studies indicating its hazard and toxicity on non-target organisms are emerging, and associations between GBHs and immune-endocrine disturbances have been described. This review aims to investigate, based on recent epidemiological studies and studies performed in vitro and in vivo in animals, the possible association between GBHs and immune-endocrine alterations. Published data suggest that GBHs have endocrine disrupting potentiality targeting sex and thyroid hormones, although its relevance for humans will require further investigations. Evidence of immunotoxicity are limited compared to those on endocrine effects, but overall highlight possible noxious effects, including lung inflammation and rhinitis. An attractive hypothesis could be the one that connects microbiota dysbiosis with possible immune-endocrine outcomes. Indeed, several intestinal microorganisms express the enzyme EPSPS and, studies are emerging that highlight a possible G-induced dysbiosis. Considering the wide use of GBHs in agriculture, further studies investigating their noxious effects at levels relevant for human exposure should be performed. A critical analysis of emerging evidence of G toxicity is required to better characterize its safety profile. In addition, attention should be paid to the differences between G alone and its formulations, which, containing substances able to increase G absorption, may present a different toxicity profile.

Identifiants

pubmed: 34246717
pii: S0300-483X(21)00174-8
doi: 10.1016/j.tox.2021.152851
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Herbicides 0
Glycine TE7660XO1C

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152851

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Ambra Maddalon (A)

Laboratory of Toxicology, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.

Valentina Galbiati (V)

Laboratory of Toxicology, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy. Electronic address: valentina.galbiati@unimi.it.

Claudio Colosio (C)

Occupational Health Unit, International Centre for Rural Health, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Stefan Mandić-Rajčević (S)

Occupational Health Unit, International Centre for Rural Health, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Emanuela Corsini (E)

Laboratory of Toxicology, Department of Environmental and Political Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH